United States: FDA Issues Final Guidance on General Wellness Products

On July 28, 2016, the United States Food and Drug Administration (FDA) finalized guidance stating that the agency does not plan to regulate "general wellness products," including software applications, provided they present a low risk to the safety of users and other persons. Under this policy, FDA will not regulate many products that the agency believes meet the statutory definition of a "device" and thus could be subject to FDA regulation. Manufacturers or developers of products that may meet the definition of general wellness products should carefully consider the limitations of this policy, with particular focus on whether their advertising claims fall within the "intended use" definitions set forth in the guidance.

Importance of "Intended Use"

Like the draft guidance, the final guidance explains that FDA will not apply either pre- or post-market regulatory requirements to "general wellness products" that pose a low risk to a user's or another person's safety. Examples of such products include software programs, exercise equipment, audio recordings, video games, personal fitness trackers, sleep monitors, and other products, including mobile applications, commonly available from retail establishments or downloaded from online sources. 

General wellness products, for the purposes of the guidance, must fall into one of two categories, based on "intended use." The intended use of a product is determined primarily by the advertising and promotional claims the manufacturer or distributor makes for the product, although it may also be determined by other circumstances surrounding the product's marketing, sale, or distribution. Under the guidance, the intended use of a general wellness product must either:

  1. relate to maintaining or encouraging a general state of health or a healthy activity, without any reference to particular diseases or conditions, or 
  2. relate to the role of a healthy lifestyle by helping to reduce the risk or impact of certain chronic diseases or conditions, where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition.

The first category is the simpler of the two to understand because it draws a bright line: it entirely excludes products not intended to address specific diseases or conditions. Such products might promote, for example, weight management, stress management, or sexual function, but without referring to particular diseases such as obesity, anxiety disorders, or erectile dysfunction. Arguably, even without this guidance document, many such products would fall outside the statutory definition of a medical device. 

The second category presents more interpretive challenges. It addresses products intended to promote, track, or encourage choices that, as part of a healthy lifestyle, "may help reduce the risk of" or "may help living well with" certain chronic diseases or conditions. The guidance states that, to fall within the intended use of a general wellness product, such lifestyle choices must be "well accepted" as playing an important role in helping patients with the particular disease or condition. FDA states that this category would apply, for example, to a software app that claims to promote physical activity, which, as part of a healthy lifestyle, may help reduce the risk of high blood pressure. Other examples FDA provides of chronic diseases for which a healthy lifestyle is associated with risk reduction or help in living well with that disease include heart disease and type 2 diabetes. FDA also provides specific examples of software apps intended to help users live well as part of a healthy lifestyle with migraine headaches and anxiety. We anticipate that many companies seeking to promote products for specific diseases or conditions will need to consider carefully whether their products meet the definition of a general wellness product under this category.

FDA also states in the guidance that a general wellness product may "only" be intended for a general wellness use. A product that has a general wellness use but also has other intended uses, therefore, would not be a general wellness product under the guidance and may be subject to FDA regulation.

Focus on Risk

In addition to having a general wellness intended use, FDA states that a product must meet additional "low risk" criteria to fall within the policy of non-regulation. In the final guidance, FDA eliminated the draft guidance's proposal that such products must have "very low" risk. The final guidance also clarifies that a product is not considered low risk, and thus not within the scope of the policy laid out in the guidance, if it (a) is "invasive" (i.e., it penetrates or pierces the skin or mucous membranes), (b) is implanted, or (c) involves technology that may pose a risk to user safety if specific regulatory controls are not applied, such as risks from lasers or radiation exposure. The final guidance eliminates some of the amorphous language that had been included in the draft, which stated that a product would not be considered low risk if it raised "novel questions of usability" or "questions of biocompatibility."

In evaluating risk, FDA recommends that manufacturers and developers consider whether FDA actively regulates products of the same type as the product in question. The guidance also gives a number of examples of products that would not be considered low risk. Examples include:

  • A sunlamp product promoted for tanning purposes, due to risks to a user's safety, including skin cancer.
  • A neurostimulation product that claims to improve memory, due to the risks to a user's safety from electrical stimulation.
  • A product that claims to enhance a user's athletic performance by providing suggestions based on the results of relative lactic acid testing, due to invasive sampling (venipuncture) and risks to other persons if specific regulatory controls are not applied (e.g., venipuncture may pose a risk of infection transmission).

Examples of products that would be considered low risk general wellness devices, by contrast, include:

  • A mobile application that plays music to "soothe and relax" an individual and to "manage stress."
  • A mobile application that solely monitors and records daily energy expenditure and cardiovascular workout activities to allow awareness of one's exercise activities to improve or maintain good cardiovascular health.
  • A mobile app that reminds users to keep exposed skin out of direct sunlight when the UV index is high.
  • A portable product intended to monitor pulse rate during exercising or hiking.
  • A product intended to mechanically exfoliate the face, hands, and feet to make the skin smoother and softer, but that cannot be used in a manner that penetrates the skin.

What's Next?

The latest FDA guidance contributes to FDA's efforts to clarify its policies regarding the regulation of products that potentially meet the definition of a medical device, with particular focus on the rapidly expanding market for digital health applications and products. This guidance is part of a broader effort by the agency to clarify its digital health policies, which have also been addressed in FDA's guidance documents on Mobile Medical Applications, Medical Device Data Systems, and medical device accessories. Another draft guidance document expected to be forthcoming would address clinical decision support (CDS) tools, and is expected to continue the general "de-regulatory" trend in the digital health area.

Developers of health-related software and other general wellness products also should bear in mind that they remain subject to other key federal and state laws and regulations. These include advertising and privacy requirements enforced by the Federal Trade Commission (FTC), product safety rules enforced by the Consumer Product Safety Commission (CPSC), HIPAA protections against unauthorized disclosure of protected health information enforced by the Department of Health and Human Services' Office of Civil Rights (HHS OCR), and state false advertising and consumer protection statutes enforced by state Attorneys General. For example, a Federal Trade Commission (FTC) action against Focus Education, a company that claimed its video games lessen the symptoms of Attention Deficit Hyperactivity Disorder, shows the importance of ensuring that all claims of health-related benefits are well substantiated.

Click here to read the FDA's notice in the Federal Register regarding the publication of its final guidance.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions